APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dihydrocodeine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Dihydrocodeine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025190 pages

Choose your research edition.

Industry ResearchDihydrocodeine Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Dihydrocodeine Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Dihydrocodeine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dihydrocodeine Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Dihydrocodeine Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Dihydrocodeine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Dihydrocodeine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dihydrocodeine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dihydrocodeine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Dihydrocodeine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dihydrocodeine include AHPL, Aspen Pharmacare, Auden Mckenzie Pharma, Daiichi Sankyo, Duopharma Biotech Berhad, Fuso Pharmaceutical, G.L. Pharma, Martindale-Hubbell and Mundipharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dihydrocodeine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dihydrocodeine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dihydrocodeine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dihydrocodeine market size, projected growth trends, production technologies, key applications, and end-use industries.

Dihydrocodeine Segment by Company

AHPL

Aspen Pharmacare

Auden Mckenzie Pharma

Daiichi Sankyo

Duopharma Biotech Berhad

Fuso Pharmaceutical

G.L. Pharma

Martindale-Hubbell

Mundipharma

Napp Pharmaceuticals

Nichi-Iko Pharmaceutical

Takata Pharmaceutical

Teofarma

Toyo Seikan Group

Wockhardt

WraSer

GlaxoSmithKline

Teva

Dihydrocodeine Segment by Type

Oral

Injection

Dihydrocodeine Segment by Application

Cough Suppressant

Analgesic

Dihydrocodeine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dihydrocodeine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dihydrocodeine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dihydrocodeine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dihydrocodeine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dihydrocodeine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Dihydrocodeine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Dihydrocodeine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Dihydrocodeine Industry Trends Table 2. Dihydrocodeine Industry Drivers Table 3. Dihydrocodeine Industry Opportunities and Challenges Table 4. Dihydrocodeine Industry Restraints Table 5. Global Dihydrocodeine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Dihydrocodeine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Dihydrocodeine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Dihydrocodeine Sales Market Share by Manufacturers Table 9. Global Dihydrocodeine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Dihydrocodeine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Dihydrocodeine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Dihydrocodeine Manufacturers, Product Type & Application Table 13. Global Dihydrocodeine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Dihydrocodeine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Oral Table 17. Major Manufacturers of Injection Table 18. Global Dihydrocodeine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Dihydrocodeine Sales by Type (2021-2026) & (K Units) Table 20. Global Dihydrocodeine Sales by Type (2027-2032) & (K Units) Table 21. Global Dihydrocodeine Sales Market Share by Type (2021-2026) Table 22. Global Dihydrocodeine Sales Market Share by Type (2027-2032) Table 23. Global Dihydrocodeine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Dihydrocodeine Revenue by Type (2021-2026) & (K Units) Table 25. Global Dihydrocodeine Revenue by Type (2027-2032) & (K Units) Table 26. Global Dihydrocodeine Revenue Market Share by Type (2021-2026) Table 27. Global Dihydrocodeine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Cough Suppressant Table 29. Major Manufacturers of Analgesic Table 30. Global Dihydrocodeine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Dihydrocodeine Sales by Application (2021-2026) & (K Units) Table 32. Global Dihydrocodeine Sales by Application (2027-2032) & (K Units) Table 33. Global Dihydrocodeine Sales Market Share by Application (2021-2026) Table 34. Global Dihydrocodeine Sales Market Share by Application (2027-2032) Table 35. Global Dihydrocodeine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Dihydrocodeine Revenue by Application (2021-2026) & (K Units) Table 37. Global Dihydrocodeine Revenue by Application (2027-2032) & (K Units) Table 38. Global Dihydrocodeine Revenue Market Share by Application (2021-2026) Table 39. Global Dihydrocodeine Revenue Market Share by Application (2027-2032) Table 40. Global Dihydrocodeine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Dihydrocodeine Sales by Region (2021-2026) & (K Units) Table 42. Global Dihydrocodeine Sales Market Share by Region (2021-2026) Table 43. Global Dihydrocodeine Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Dihydrocodeine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Dihydrocodeine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Dihydrocodeine Sales by Country (2021-2026) & (K Units) Table 47. North America Dihydrocodeine Sales by Country (2027-2032) & (K Units) Table 48. Europe Dihydrocodeine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Dihydrocodeine Sales by Country (2021-2026) & (K Units) Table 50. Europe Dihydrocodeine Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Dihydrocodeine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Dihydrocodeine Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Dihydrocodeine Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Dihydrocodeine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Dihydrocodeine Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Dihydrocodeine Sales by Country (2027-2032) & (K Units) Table 57. Global Dihydrocodeine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Dihydrocodeine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Dihydrocodeine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Dihydrocodeine Revenue Market Share by Region (2021-2026) Table 61. Global Dihydrocodeine Revenue Market Share by Region (2027-2032) Table 62. AHPL Company Information Table 63. AHPL Business Overview Table 64. AHPL Dihydrocodeine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. AHPL Dihydrocodeine Product Portfolio Table 66. AHPL Recent Development Table 67. Aspen Pharmacare Company Information Table 68. Aspen Pharmacare Business Overview Table 69. Aspen Pharmacare Dihydrocodeine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Aspen Pharmacare Dihydrocodeine Product Portfolio Table 71. Aspen Pharmacare Recent Development Table 72. Auden Mckenzie Pharma Company Information Table 73. Auden Mckenzie Pharma Business Overview Table 74. Auden Mckenzie Pharma Dihydrocodeine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Auden Mckenzie Pharma Dihydrocodeine Product Portfolio Table 76. Auden Mckenzie Pharma Recent Development Table 77. Daiichi Sankyo Company Information Table 78. Daiichi Sankyo Business Overview Table 79. Daiichi Sankyo Dihydrocodeine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Daiichi Sankyo Dihydrocodeine Product Portfolio Table 81. Daiichi Sankyo Recent Development Table 82. Duopharma Biotech Berhad Company Information Table 83. Duopharma Biotech Berhad Business Overview Table 84. Duopharma Biotech Berhad Dihydrocodeine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Duopharma Biotech Berhad Dihydrocodeine Product Portfolio Table 86. Duopharma Biotech Berhad Recent Development Table 87. Fuso Pharmaceutical Company Information Table 88. Fuso Pharmaceutical Business Overview Table 89. Fuso Pharmaceutical Dihydrocodeine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Fuso Pharmaceutical Dihydrocodeine Product Portfolio Table 91. Fuso Pharmaceutical Recent Development Table 92. G.L. Pharma Company Information Table 93. G.L. Pharma Business Overview Table 94. G.L. Pharma Dihydrocodeine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. G.L. Pharma Dihydrocodeine Product Portfolio Table 96. G.L. Pharma Recent Development Table 97. Martindale-Hubbell Company Information Table 98. Martindale-Hubbell Business Overview Table 99. Martindale-Hubbell Dihydrocodeine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Martindale-Hubbell Dihydrocodeine Product Portfolio Table 101. Martindale-Hubbell Recent Development Table 102. Mundipharma Company Information Table 103. Mundipharma Business Overview Table 104. Mundipharma Dihydrocodeine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Mundipharma Dihydrocodeine Product Portfolio Table 106. Mundipharma Recent Development Table 107. Napp Pharmaceuticals Company Information Table 108. Napp Pharmaceuticals Business Overview Table 109. Napp Pharmaceuticals Dihydrocodeine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Napp Pharmaceuticals Dihydrocodeine Product Portfolio Table 111. Napp Pharmaceuticals Recent Development Table 112. Nichi-Iko Pharmaceutical Company Information Table 113. Nichi-Iko Pharmaceutical Business Overview Table 114. Nichi-Iko Pharmaceutical Dihydrocodeine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Nichi-Iko Pharmaceutical Dihydrocodeine Product Portfolio Table 116. Nichi-Iko Pharmaceutical Recent Development Table 117. Takata Pharmaceutical Company Information Table 118. Takata Pharmaceutical Business Overview Table 119. Takata Pharmaceutical Dihydrocodeine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Takata Pharmaceutical Dihydrocodeine Product Portfolio Table 121. Takata Pharmaceutical Recent Development Table 122. Teofarma Company Information Table 123. Teofarma Business Overview Table 124. Teofarma Dihydrocodeine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Teofarma Dihydrocodeine Product Portfolio Table 126. Teofarma Recent Development Table 127. Toyo Seikan Group Company Information Table 128. Toyo Seikan Group Business Overview Table 129. Toyo Seikan Group Dihydrocodeine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Toyo Seikan Group Dihydrocodeine Product Portfolio Table 131. Toyo Seikan Group Recent Development Table 132. Wockhardt Company Information Table 133. Wockhardt Business Overview Table 134. Wockhardt Dihydrocodeine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Wockhardt Dihydrocodeine Product Portfolio Table 136. Wockhardt Recent Development Table 137. WraSer Company Information Table 138. WraSer Business Overview Table 139. WraSer Dihydrocodeine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. WraSer Dihydrocodeine Product Portfolio Table 141. WraSer Recent Development Table 142. GlaxoSmithKline Company Information Table 143. GlaxoSmithKline Business Overview Table 144. GlaxoSmithKline Dihydrocodeine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. GlaxoSmithKline Dihydrocodeine Product Portfolio Table 146. GlaxoSmithKline Recent Development Table 147. Teva Company Information Table 148. Teva Business Overview Table 149. Teva Dihydrocodeine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Teva Dihydrocodeine Product Portfolio Table 151. Teva Recent Development Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Dihydrocodeine Distributors List Table 155. Dihydrocodeine Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Dihydrocodeine Product Image Figure 2. Global Dihydrocodeine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dihydrocodeine Market Size (2021-2032) & (US$ Million) Figure 4. Global Dihydrocodeine Sales (2021-2032) & (K Units) Figure 5. Global Dihydrocodeine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Dihydrocodeine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Oral Image Figure 9. Injection Image Figure 10. Global Dihydrocodeine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Dihydrocodeine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Dihydrocodeine Sales Market Share by Type (2021-2032) Figure 13. Global Dihydrocodeine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Dihydrocodeine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Dihydrocodeine Revenue Market Share by Type (2021-2032) Figure 16. Cough Suppressant Image Figure 17. Analgesic Image Figure 18. Global Dihydrocodeine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Dihydrocodeine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Dihydrocodeine Sales Market Share by Application (2021-2032) Figure 21. Global Dihydrocodeine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Dihydrocodeine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Dihydrocodeine Revenue Market Share by Application (2021-2032) Figure 24. North America Dihydrocodeine Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Dihydrocodeine Sales Market Share by Country (2021-2032) Figure 26. U.S. Dihydrocodeine Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Dihydrocodeine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Dihydrocodeine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Dihydrocodeine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Dihydrocodeine Sales Market Share by Country (2021-2032) Figure 31. Germany Dihydrocodeine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Dihydrocodeine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Dihydrocodeine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Dihydrocodeine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Dihydrocodeine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Dihydrocodeine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Dihydrocodeine Sales Market Share by Country (2021-2032) Figure 38. China Dihydrocodeine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Dihydrocodeine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Dihydrocodeine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Dihydrocodeine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Dihydrocodeine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Dihydrocodeine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Dihydrocodeine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Dihydrocodeine Sales Market Share by Country (2021-2032) Figure 46. Brazil Dihydrocodeine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Dihydrocodeine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Dihydrocodeine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Dihydrocodeine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Dihydrocodeine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Dihydrocodeine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Dihydrocodeine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Dihydrocodeine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Dihydrocodeine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Dihydrocodeine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Dihydrocodeine Revenue (2021-2032) & (US$ Million) Figure 57. North America Dihydrocodeine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Dihydrocodeine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Dihydrocodeine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Dihydrocodeine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Dihydrocodeine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Dihydrocodeine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Dihydrocodeine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Dihydrocodeine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Dihydrocodeine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Cough Suppressant
  • Analgesic
Companies covered
  • AHPL
  • Aspen Pharmacare
  • Auden Mckenzie Pharma
  • Daiichi Sankyo
  • Duopharma Biotech Berhad
  • Fuso Pharmaceutical
  • G.L. Pharma
  • Martindale-Hubbell
  • Mundipharma
  • Napp Pharmaceuticals
  • Nichi-Iko Pharmaceutical
  • Takata Pharmaceutical
  • Teofarma
  • Toyo Seikan Group
  • Wockhardt
  • WraSer
  • GlaxoSmithKline
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Dihydrocodeine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Dihydrocodeine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Dihydrocodeine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Dihydrocodeine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Dihydrocodeine Market Dynamics
  1. 2.1 Dihydrocodeine Industry Trends
  2. 2.2 Dihydrocodeine Industry Drivers
  3. 2.3 Dihydrocodeine Industry Opportunities and Challenges
  4. 2.4 Dihydrocodeine Industry Restraints
3 Dihydrocodeine Market by Manufacturers
  1. 3.1 Global Dihydrocodeine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Dihydrocodeine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Dihydrocodeine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Dihydrocodeine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dihydrocodeine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Dihydrocodeine Manufacturers, Product Type & Application
  7. 3.7 Global Dihydrocodeine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dihydrocodeine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dihydrocodeine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dihydrocodeine Tier 1, Tier 2, and Tier 3
4 Dihydrocodeine Market by Type
  1. 4.1 Dihydrocodeine Type Introduction
  2. 4.1.1 Oral
  3. 4.1.2 Injection
  4. 4.2 Global Dihydrocodeine Sales by Type
  5. 4.2.1 Global Dihydrocodeine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Dihydrocodeine Sales by Type (2021-2032)
  7. 4.2.3 Global Dihydrocodeine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Dihydrocodeine Revenue by Type
  9. 4.3.1 Global Dihydrocodeine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Dihydrocodeine Revenue by Type (2021-2032)
  11. 4.3.3 Global Dihydrocodeine Revenue Market Share by Type (2021-2032)
5 Dihydrocodeine Market by Application
  1. 5.1 Dihydrocodeine Application Introduction
  2. 5.1.1 Cough Suppressant
  3. 5.1.2 Analgesic
  4. 5.2 Global Dihydrocodeine Sales by Application
  5. 5.2.1 Global Dihydrocodeine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Dihydrocodeine Sales by Application (2021-2032)
  7. 5.2.3 Global Dihydrocodeine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Dihydrocodeine Revenue by Application
  9. 5.3.1 Global Dihydrocodeine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Dihydrocodeine Revenue by Application (2021-2032)
  11. 5.3.3 Global Dihydrocodeine Revenue Market Share by Application (2021-2032)
6 Global Dihydrocodeine Sales by Region
  1. 6.1 Global Dihydrocodeine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dihydrocodeine Sales by Region (2021-2032)
  3. 6.2.1 Global Dihydrocodeine Sales by Region (2021-2026)
  4. 6.2.2 Global Dihydrocodeine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Dihydrocodeine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Dihydrocodeine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Dihydrocodeine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Dihydrocodeine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Dihydrocodeine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Dihydrocodeine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Dihydrocodeine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Dihydrocodeine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Dihydrocodeine Revenue by Region
  1. 7.1 Global Dihydrocodeine Revenue by Region
  2. 7.1.1 Global Dihydrocodeine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Dihydrocodeine Revenue by Region (2021-2026)
  4. 7.1.3 Global Dihydrocodeine Revenue by Region (2027-2032)
  5. 7.1.4 Global Dihydrocodeine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Dihydrocodeine Revenue (2021-2032)
  8. 7.2.2 North America Dihydrocodeine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Dihydrocodeine Revenue (2021-2032)
  11. 7.3.2 Europe Dihydrocodeine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Dihydrocodeine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Dihydrocodeine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Dihydrocodeine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Dihydrocodeine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AHPL
  2. 8.1.1 AHPL Company Information
  3. 8.1.2 AHPL Business Overview
  4. 8.1.3 AHPL Dihydrocodeine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AHPL Dihydrocodeine Product Portfolio
  6. 8.1.5 AHPL Recent Developments
  7. 8.2 Aspen Pharmacare
  8. 8.2.1 Aspen Pharmacare Company Information
  9. 8.2.2 Aspen Pharmacare Business Overview
  10. 8.2.3 Aspen Pharmacare Dihydrocodeine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Aspen Pharmacare Dihydrocodeine Product Portfolio
  12. 8.2.5 Aspen Pharmacare Recent Developments
  13. 8.3 Auden Mckenzie Pharma
  14. 8.3.1 Auden Mckenzie Pharma Company Information
  15. 8.3.2 Auden Mckenzie Pharma Business Overview
  16. 8.3.3 Auden Mckenzie Pharma Dihydrocodeine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Auden Mckenzie Pharma Dihydrocodeine Product Portfolio
  18. 8.3.5 Auden Mckenzie Pharma Recent Developments
  19. 8.4 Daiichi Sankyo
  20. 8.4.1 Daiichi Sankyo Company Information
  21. 8.4.2 Daiichi Sankyo Business Overview
  22. 8.4.3 Daiichi Sankyo Dihydrocodeine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Daiichi Sankyo Dihydrocodeine Product Portfolio
  24. 8.4.5 Daiichi Sankyo Recent Developments
  25. 8.5 Duopharma Biotech Berhad
  26. 8.5.1 Duopharma Biotech Berhad Company Information
  27. 8.5.2 Duopharma Biotech Berhad Business Overview
  28. 8.5.3 Duopharma Biotech Berhad Dihydrocodeine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Duopharma Biotech Berhad Dihydrocodeine Product Portfolio
  30. 8.5.5 Duopharma Biotech Berhad Recent Developments
  31. 8.6 Fuso Pharmaceutical
  32. 8.6.1 Fuso Pharmaceutical Company Information
  33. 8.6.2 Fuso Pharmaceutical Business Overview
  34. 8.6.3 Fuso Pharmaceutical Dihydrocodeine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Fuso Pharmaceutical Dihydrocodeine Product Portfolio
  36. 8.6.5 Fuso Pharmaceutical Recent Developments
  37. 8.7 G.L. Pharma
  38. 8.7.1 G.L. Pharma Company Information
  39. 8.7.2 G.L. Pharma Business Overview
  40. 8.7.3 G.L. Pharma Dihydrocodeine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 G.L. Pharma Dihydrocodeine Product Portfolio
  42. 8.7.5 G.L. Pharma Recent Developments
  43. 8.8 Martindale-Hubbell
  44. 8.8.1 Martindale-Hubbell Company Information
  45. 8.8.2 Martindale-Hubbell Business Overview
  46. 8.8.3 Martindale-Hubbell Dihydrocodeine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Martindale-Hubbell Dihydrocodeine Product Portfolio
  48. 8.8.5 Martindale-Hubbell Recent Developments
  49. 8.9 Mundipharma
  50. 8.9.1 Mundipharma Company Information
  51. 8.9.2 Mundipharma Business Overview
  52. 8.9.3 Mundipharma Dihydrocodeine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mundipharma Dihydrocodeine Product Portfolio
  54. 8.9.5 Mundipharma Recent Developments
  55. 8.10 Napp Pharmaceuticals
  56. 8.10.1 Napp Pharmaceuticals Company Information
  57. 8.10.2 Napp Pharmaceuticals Business Overview
  58. 8.10.3 Napp Pharmaceuticals Dihydrocodeine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Napp Pharmaceuticals Dihydrocodeine Product Portfolio
  60. 8.10.5 Napp Pharmaceuticals Recent Developments
  61. 8.11 Nichi-Iko Pharmaceutical
  62. 8.11.1 Nichi-Iko Pharmaceutical Company Information
  63. 8.11.2 Nichi-Iko Pharmaceutical Business Overview
  64. 8.11.3 Nichi-Iko Pharmaceutical Dihydrocodeine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Nichi-Iko Pharmaceutical Dihydrocodeine Product Portfolio
  66. 8.11.5 Nichi-Iko Pharmaceutical Recent Developments
  67. 8.12 Takata Pharmaceutical
  68. 8.12.1 Takata Pharmaceutical Company Information
  69. 8.12.2 Takata Pharmaceutical Business Overview
  70. 8.12.3 Takata Pharmaceutical Dihydrocodeine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Takata Pharmaceutical Dihydrocodeine Product Portfolio
  72. 8.12.5 Takata Pharmaceutical Recent Developments
  73. 8.13 Teofarma
  74. 8.13.1 Teofarma Company Information
  75. 8.13.2 Teofarma Business Overview
  76. 8.13.3 Teofarma Dihydrocodeine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Teofarma Dihydrocodeine Product Portfolio
  78. 8.13.5 Teofarma Recent Developments
  79. 8.14 Toyo Seikan Group
  80. 8.14.1 Toyo Seikan Group Company Information
  81. 8.14.2 Toyo Seikan Group Business Overview
  82. 8.14.3 Toyo Seikan Group Dihydrocodeine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Toyo Seikan Group Dihydrocodeine Product Portfolio
  84. 8.14.5 Toyo Seikan Group Recent Developments
  85. 8.15 Wockhardt
  86. 8.15.1 Wockhardt Company Information
  87. 8.15.2 Wockhardt Business Overview
  88. 8.15.3 Wockhardt Dihydrocodeine Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Wockhardt Dihydrocodeine Product Portfolio
  90. 8.15.5 Wockhardt Recent Developments
  91. 8.16 WraSer
  92. 8.16.1 WraSer Company Information
  93. 8.16.2 WraSer Business Overview
  94. 8.16.3 WraSer Dihydrocodeine Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 WraSer Dihydrocodeine Product Portfolio
  96. 8.16.5 WraSer Recent Developments
  97. 8.17 GlaxoSmithKline
  98. 8.17.1 GlaxoSmithKline Company Information
  99. 8.17.2 GlaxoSmithKline Business Overview
  100. 8.17.3 GlaxoSmithKline Dihydrocodeine Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 GlaxoSmithKline Dihydrocodeine Product Portfolio
  102. 8.17.5 GlaxoSmithKline Recent Developments
  103. 8.18 Teva
  104. 8.18.1 Teva Company Information
  105. 8.18.2 Teva Business Overview
  106. 8.18.3 Teva Dihydrocodeine Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Teva Dihydrocodeine Product Portfolio
  108. 8.18.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dihydrocodeine Value Chain Analysis
  2. 9.1.1 Dihydrocodeine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dihydrocodeine Production Mode & Process
  6. 9.2 Dihydrocodeine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dihydrocodeine Distributors
  9. 9.2.3 Dihydrocodeine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst